Cancer Prevention and Research Institute of Texas logo
CPRIT Product Development Research

CPRIT PDR — Texas Device and Diagnostics Company

Funds Texas firms developing cancer diagnostics, companion tools, and biomarkers for clinical deployment.

OpenCancer Prevention and Research Institute of TexasUnited StatesEligible in Texas

The CPRIT Texas Device and Diagnostics Company RFA is a Product Development Research mechanism administered by the Cancer Prevention and Research Institute of Texas, which allocates approximately $70 million per fiscal year across its four product development tracks. The Device and Diagnostics RFA funds Texas-based for-profit companies developing devices and assays for cancer detection, diagnosis,

Cancer detection, diagnosis, prognosis, monitoring, and treatment devices and assays — including companion diagnostics and early-lesion tests — for Texas companies near regulatory submission.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Rolling
Next deadlineiThe next date applications are due. Rolling means you can apply any time.Rolling
Decision timeiTypical time from the deadline to the funder's decision.4 weeks
Project durationiHow long the funded work is expected to run.36 months
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Royalty-back
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.50%
Funding pooliThe total budget available across all awards in this round.

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see the timeline

Last verified: 22 Jul 2026Source: cprit.texas.gov